SUBSCRIBE
SUBSCRIBE

Organon

NEWS
Business
Movers and Shakers Oct. 1
Here’s a look at who shook things up in the world of pharma and biotech this week.
September 28, 2018
 · 
4 min read
 · 
Alex Keown
Future Leaders of the Next Generation of Business People
Business
A Flurry of Leadership Changes in Biotech
The past few days has had a flurry of activity in the industry with leadership changes. Let’s take a look at some of those!
September 26, 2018
 · 
3 min read
 · 
Alex Keown
Biotech Beach
The Day In Review: Schering-Plough Corporation Buys Organon For $14.4 Billion
March 12, 2007
 · 
1 min read
BioForest
National Institutes of Health (NIH) Awards Nearly $11.5 Million To Support Science Education Programs
January 4, 2007
 · 
1 min read
Biotech Beach
The Day In Review: ImClone Systems Incorporated Loses Erbitux Patent Fight
September 19, 2006
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Organon Reports Results for the First Quarter Ended March 31, 2026
April 30, 2026
 · 
18 min read
Press Releases
Organon Cancels First Quarter 2026 Earnings Call
April 29, 2026
 · 
2 min read
Press Releases
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
April 29, 2026
 · 
8 min read
Press Releases
Sun Pharma signs Definitive Agreement to Acquire Organon
April 26, 2026
 · 
11 min read
Press Releases
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026
April 17, 2026
 · 
2 min read
Press Releases
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
April 15, 2026
 · 
6 min read
Press Releases
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age
March 27, 2026
 · 
7 min read
Press Releases
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis
February 27, 2026
 · 
7 min read
Press Releases
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
February 23, 2026
 · 
9 min read
Press Releases
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 12, 2026
 · 
20 min read
Load More